---
title: The Smell of Breast Milk and Therapeutic Positions in Comfort
nct_id: NCT06826053
overall_status: COMPLETED
phase: NA
sponsor: Karamanoğlu Mehmetbey University
study_type: INTERVENTIONAL
primary_condition: Respiratory Distress
countries: Turkey (Türkiye)
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06826053.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06826053"
ct_last_update_post_date: 2025-02-18
last_seen_at: "2026-05-12T07:11:33.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# The Smell of Breast Milk and Therapeutic Positions in Comfort

**Official Title:** The Effect of Therapeutic Positions and the Smell of Breast Milk on Comfort and Vital Signs in Term Neonates With Respiratory Distress

**NCT ID:** [NCT06826053](https://clinicaltrials.gov/study/NCT06826053)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 70
- **Lead Sponsor:** Karamanoğlu Mehmetbey University
- **Conditions:** Respiratory Distress
- **Start Date:** 2024-03-01
- **Completion Date:** 2024-07-30
- **CT.gov Last Update:** 2025-02-18

## Brief Summary

Before starting the data collection process, a pilot study was conducted with 10 preterm newborns, five in the safe swaddling group and five in the control group, to evaluate the comprehensibility of the questionnaire form and the feasibility of the application. The newborns included in the pilot study were not included in the study.

At the beginning of the study, parents of newborns who met the sample selection criteria were informed about the purpose and content of the study and informed consent was obtained from those who agreed to participate in the study. Data were obtained from parents of infants 38 weeks and older who were hospitalized in the Tertiary NICU and who met the sample selection criteria by using data collection tools. Firstly, parents were informed about the study through the "Information and Informed Consent Form" (Appendix-E). They were included in the study if they volunteered. Written informed consent was obtained from the parents who volunteered to participate in the study. Data were collected using "Data Collection Tools" prepared by the researcher.

Newborns will be randomly divided into two groups;

* Group 1: Therapeutic position
* Group 2: Therapeutic position + the smell of breast milk Number, percentage, mean and standard deviation will be used in the descriptive statistics of the study. The normality of the data will be evaluated with the Kolmogrow Smirnow test. Kappa analysis will be used in the evaluation of inter-observer agreement. Chi-square test will be used for the comparison of categorical data, t test and Anova in independent groups will be used for the comparison of normally distributed data, Friedman, Wilcoxon, Mann Whitney U and Kruskal Wallis tests will be used for the comparison of non-normally distributed data. Within-group evaluation will be evaluated by repeated measures analysis of variance. Significance level p\<0.05 will be accepted.

Continuous data will be shown as mean ± standard deviation for normally distributed data, median and 25-75th quartile for non-normally distributed data, and frequency and percentage for categorical data. For comparisons of differences between categorical variables by groups, Pearson chi-square test will be used for RxC tables with expected observations of 5 and above and Fisher Freeman Halton test will be used for RxC tables with expected observations below 5.

## Detailed Description

Ethical and institutional permissions were obtained before starting to collect the data. Written consent will be obtained from all parents via a voluntary consent form. Newborns will be randomly selected into 2 groups.

Group 1: term neonates in four different therapeutic positions (prone-right lateral-supine-left lateral). The positions of the newborns will be changed every two hours in sequence. In addition, peak heart rate, respiration, oxygen saturation, comfort (2 observers), pain (2 observers), distress (2 observers) will be evaluated every 30 minutes for two hours. A total of 5 measurements and evaluations will be performed.

Group 2: Therapeutic position + the smell of breast milk . The positions of the newborns will be changed every two hours in sequence. Newborns in this group will also be made to smell the odor of breast milk. For breast milk odor, approximately 3-5 cc of breast milk obtained from each baby\'s own mother\'s milk will be dripped onto 4x4 gauze swabs. These gauze pads dripped with breast milk will be placed at a distance of approximately 10 cm from the baby\'s nose. Then, peak heart rate, respiration, oxygen saturation, comfort (2 observers), pain (2 observers), distress (2 observers) values of the newborn will be evaluated every 30 minutes for two hours. A total of 5 measurements and evaluations will be performed.

Hypotheses of the Study H1: Different therapeutic positions given to newborns have an effect on respiratory rate.

H2: Different therapeutic positions given to newborns have an effect on peak heart rate.

H3: Different therapeutic positions given to newborns have an effect on oxygen saturation.

H4: Different therapeutic positions given to newborns have an effect on comfort level.

H5: Different positions given to newborns and breast milk odor have an effect on respiratory rate.

H6: Different positions given to newborns and breast milk odor have an effect on peak heart rate.

H7: Different positions given to newborns and breast milk odor have an effect on oxygen saturation.

H8: Different positions given to newborns and breast milk odor have an effect on comfort level.

H9: There is a significant difference between the two groups in terms of respiratory rate of newborns.

H10: There is a significant difference between the two groups in terms of peak heart rate of newborns.

H11: There is a significant difference between the two groups in terms of oxygen saturation of newborns.

H12: There is a significant difference between the two groups in terms of comfort level of newborns.

## Eligibility

- **Minimum age:** 1 Day
- **Maximum age:** 28 Days
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* NICU admission immediately after birth.
* The babies were term births (births at 38 weeks and above).
* The baby was not given analgesics and/or sedatives.
* The baby had spontaneous breathing.
* Families\' acceptance to participate in the study.

Exclusion Criteria:

* With a thoracic tube, umbilical vein catheter or dialysis catheter.
* With active infection.
* Tachypnea and unstable oxygen saturation ≤ 90%.
* Receiving sedation therapy.
```

## Arms

- **Therapeutic position group** (EXPERIMENTAL) — Therapeutic group
- **Therapeutic position + smell of breast milk** (EXPERIMENTAL) — Therapeutic position + smell of breast milk

## Interventions

- **Therapeutic position** (OTHER) — each newborn was given four different therapeutic positions in sequence.
- **Therapeutic position + smell breast milk** (OTHER) — each newborn will be given four different therapeutic positions in sequence and will be made to smell the scent of breast milk.

## Primary Outcomes

- **heart rate** _(time frame: every 30 minutes for two hours)_ — heart rate
- **oxygen saturation values** _(time frame: every 30 minutes for two hour)_ — oxygen saturation values
- **respiratory rate** _(time frame: every 30 minutes for two hours)_ — respiratory rate

## Secondary Outcomes

- **Neonatal Comfort Behavior Scale Score** _(time frame: every 30 minutes for two hours)_

## Locations (1)

- Karamanoglu Mehmetbey University, Karaman, Turkey (Türkiye)

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.karamanoglu mehmetbey university|karaman||turkey (türkiye)` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06826053.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06826053*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*